Cervical cancer screening company TruScreen faces trading suspension for late annual report

Cervical cancer screening company TruScreen faces trading suspension for late annual report
Martin Dillon was reappointed chief executive of TruScreen in March. (Image: TruScreen)
Rebecca Stevenson
Cancer screening company TruScreen must file its late annual report by July 8 or face a trading suspension. In a notice to the New Zealand Exchange (NZX), market watchdog NZX RegCo said the firm should have filed its annual report by July 1. NZ RegCo said that because TruScreen missed that deadline, it had five business days following July 1 to publish the report to the NZX. If the report is not published, share trading for TruScreen will be suspended from the market from opening on Tuesday, July 9, until it is filed.TruScreen sh...

More Markets

Forsyth Barr initiates full coverage of Turners at outperform
Markets

Forsyth Barr initiates full coverage of Turners at outperform

Forsyth Barr says a premium valuation is now warranted. 

The kiwi dollar is falling prey to the bears
Economy

The kiwi dollar is falling prey to the bears

The only worst performer is the Norwegian krone.

The Warehouse’s plight in five charts
Retail Charts

The Warehouse’s plight in five charts

The private equity bid shows the company’s future is still anyone’s guess.

NZ sharemarket down over 1%
Markets Market close

NZ sharemarket down over 1%

The S&P/NZX 50 Index closed at 12,396.27, down 134.72 points or 1.08%.

Graham Skellern 25 Jul 2024